In present study SOD2 has found to be downregulated, one of previous study has demonstrating the similar findings as it has been reported that SOD2 showed downregulated expression in breast, esophageal and pancreatic cancers [65]. Here, SOD2 is linked to familial pancreatic carcinoma.